Author

Hirotaka Mizuno

Ono Pharmaceutical (Japan)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2

Frequent Co-Authors

Anna C. LoveiD· 1 shared Armin C. BrauniD· 1 shared Bradley S. MooreiD· 1 shared Danny David JonigkiD· 1 shared David Coronel· 1 shared Douglas J. SheffleriD· 1 shared Frank NoéiD· 1 shared Heike Hofmann-Winkler· 1 shared

Activity by Year

2021-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

Anna C. LoveORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BiochemistrybioRxivPreprintSep 22, 2026

A phytocannabinoid-sensitive phosphorylation switch converts endocannabinoids into alternative lipid GPCR activators

Anna C. Love, Yasuyuki Kihara, Hirotaka Mizuno…·Jerold J. M. Chun

The paper shows that phosphorylation of anandamide by DGKQ converts it into AEAp, which acts as a ligand for LPARs and MRGPRX4, linking eCB metabolism to Cannabis pharmacology.

DOI 10.64898/2026.09.21.753239

humanexperimental assay

𝕏 PostBluesky

Molecular BiologyEBioMedicinePeer-reviewedMar 1, 2021

Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity

Markus Hoffmann, Heike Hofmann-Winkler, Joan C. Smith…·Stefan Pöhlmann

This study shows camostat mesylate inhibits SARS-CoV-2 by blocking TMPRSS2 and its metabolite GBPA also has antiviral activity, suggesting no resistance through TMPRSS2-related proteases.

387 citationstop 1%

humanexperimental assay

𝕏 PostBluesky